logo-loader

Auscann targeting pain management with Australian cannabinoid products

Last updated: 13:55 06 Sep 2018 AEST, First published: 23:55 05 Sep 2018 AEST

Elaine Darby, managing director of Auscann Group Holdings Ltd (ASX:AC8), spoke to Proactive Investors at the ASX Small and Mid-Cap Conference in Sydney.

Auscann is continuing to make steady progress towards releasing its first medicinal cannabis products during the financial year 2019. The company has established several strategic partnerships in Australia, Chile and Canada and is advancing its position as a fully-integrated cannabinoid pharmaceutical company.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

4 hours, 40 minutes ago